Learn More
Medchemexpress LLC Galiximab 10mg | 10mg

Supplier: Medchemexpress LLC HYP9929310MG
Galiximab (IDEC-114) is a primatized monoclonal IgG1 antibody targeting CD80 Galiximab variable regions are primatized and the constant regions are humanized Galiximab induces antibody-dependent cellular cytotoxicity by blocking CD80-CD28 binding Galiximab has antitumor activity and can induce apoptosis in tumor cells Galiximab can be used in the research of relapsed Hodgkin lymphoma and solid tumors[1][2]
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.